Experimental Infection Medicine

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Infectious Medicine


The area of Experimental Infection Medicine encompasses beneficial and detrimental aspects of microbes: 1. Benevolent bacteria We are all colonized by a plethora of bacteria, but remain healthy. Can specific beneficial bacteria contribute to health? We are investigating the impact of bacteria (probiotics) and bacterial proteins in maintaining health. 2. Killing of bacteria The Lood lab uses novel experimental means to combat infections which include predatory bacteria, bacteriophages and phage enzymes. 3. Antibiotic resistance We are investigating the biology behind, and means to limit the spread of mobile genetic elements (e.g. phage), which can generate antibiotic resistant bacterial infections. The lab focuses on translational research, collaborating with medical doctors, chemists, engineers, mathematicians, genetics, biotechnologists, biomedicine professionals, evolutionary biologists, and interact with several industrial partners; working with both basic and applied research.

Recent research outputs

Holger Brüggemann, Llanos Salar-Vidal, Harald P.M. Gollnick & Rolf Lood, 2021 May 31, In: Frontiers in Microbiology. 12, 673845.

Research output: Contribution to journalReview article

Hamed Khakzad, Lotta Happonen, Yasaman Karami, Sounak Chowdhury, Gizem Ertürk Bergdahl, Michael Nilges, Guy Tran Van Nhieu, Johan Malmström & Lars Malmström, 2021 Jan 7, In: PLoS Computational Biology. 17, 1, e1008169.

Research output: Contribution to journalArticle

View All (23)